Travere Therapeutics Receives USPTO Notice Of Allowance For Filspari Patent In FSGS
TVTX•USPTO notice of allowance for Filspari patent
Sept. 23 (Reuters) - Travere Therapeutics, Inc. TVTX.O:
- Travere Therapeutics receives USPTO notice of allowance for a Filspari patent in FSGS.
- Travere Therapeutics said it will submit the issued patent for FDA Orange Book listing.
Source text: ID:nBw47PYt0a
